Myriad Genetics |
Date/Time | / |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | - |
Previous Close | - |
High | - |
Low | - |
Volume [USD] | - |
Volume [Units] | |
Price fixings | |
ISIN | US62855J1043 |
Security | MYGN |
Exchange | IEX |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 22.6100 | ![]() |
271,440 |
Cboe US | 22.65 | ![]() |
11,895 |
IEX | 22.57 | ![]() |
9,631 |
TradeGate | 20.960 | ![]() |
10 |
Hannover | 21.520 | ![]() |
0 |
Frankfurt | 21.5100 | ![]() |
0 |
Berlin | 21.510 | ![]() |
0 |
München | 21.690 | ![]() |
0 |
Hamburg | 21.510 | ![]() |
0 |
Düsseldorf | 20.830 | ![]() |
0 |
Lang & Schwa.. | 20.820 | ![]() |
|
Stuttgart | 20.940 | ![]() |
|
gettex | 20.820 | ![]() |
|
Quotrix | 21.5800 | ![]() |
|
London Domes.. | 20.24 | 17 | |
Xetra | 26.720 | 0 |
News
- Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care
03/14/2022 / 12:05 - GlobeNewswire - Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
03/12/2022 / 01:05 - GlobeNewswire - Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies
03/08/2022 / 13:22 - GlobeNewswire - Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference
03/02/2022 / 22:30 - GlobeNewswire - Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
02/24/2022 / 15:00 - GlobeNewswire
Personal area
Click on
to activate push quotes.
